# Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

> **NCT00926224** · NA · COMPLETED · sponsor: **Echosens** · enrollment: 300 (estimated)

## Conditions studied

- Liver Fibrosis
- Cirrhosis

## Interventions

- **DEVICE:** FibroScan M and XL probes

## Key facts

- **NCT ID:** NCT00926224
- **Lead sponsor:** Echosens
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2010-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2010-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926224, "Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00926224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*